{"pub_date": "2016-03-06T00:00:00Z", "subsection_name": null, "lead_paragraph": "A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals\u2019 financial disclosures, despite attempts to burnish results.", "print_page": "1", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "MORGENSON", "firstname": "Gretchen", "role": "reported"}], "original": "By GRETCHEN MORGENSON"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/03/06/business/06gret1/06gret1-thumbWide-v3.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/03/06/business/06gret1/06gret1-thumbWide-v3.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 527, "url": "images/2016/03/06/business/06gret1/06gret1-articleLarge-v3.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "527", "xlarge": "images/2016/03/06/business/06gret1/06gret1-articleLarge-v3.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/03/06/business/06gret1/06gret1-thumbStandard-v3.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/03/06/business/06gret1/06gret1-thumbStandard-v3.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"content_kicker": "Fair Game", "print_headline": "A Troubling Blooper Reel at Valeant", "main": "A Troubling Timeline at Valeant", "kicker": "Fair Game"}, "source": "The New York Times", "blog": [], "word_count": "999", "web_url": "http://www.nytimes.com/2016/03/06/business/a-troubling-timeline-at-valeant.html", "slideshow_credits": null, "news_desk": "SundayBusiness", "type_of_material": "News", "snippet": "A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals\u2019 financial disclosures, despite attempts to burnish results.", "_id": "56d9cd9c38f0d83eee09783c", "abstract": "Gretchen Morgenson Fair Game column questions why Wall Street analysts continue to support Valeant Pharmaceuticals International; notes company misstated earnings and tried to keep investors in dark about SEC investigation. ", "keywords": [{"rank": "1", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Company Reports", "is_major": "N"}, {"rank": "3", "name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N"}]}